In-Vitro Toxicology Testing Market Report 2026

In-Vitro Toxicology Testing Market Overview

• In-Vitro Toxicology Testing market size has reached to $12.73 billion in 2025 • Expected to grow to $20.87 billion in 2030 at a compound annual growth rate (CAGR) of 10.3% • Growth Driver: Growing Healthcare Expenditure Fuels In-Vitro Toxicology Testing Market Growth • Market Trend: Strategic Partnerships Drive Innovation In In-Vitro Inhalation Toxicology Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under In-Vitro Toxicology Testing Market?

In-vitro toxicology testing refers to assays and tests used to determine toxic doses of drugs, nutraceuticals, and food additives that cause toxicity when administered. It is used to detect the presence of toxic chemicals, and residual solvents and reduce hazardous exposure. This testing is mostly used to determine the doses of medications that exhibit toxicity in preclinical development, along with drug discovery and development. The main products of in-vitro toxicology testing are consumables, assays, equipment, software, and services. Consumables refer to all the products that are used in laboratory testing of compounds such as cannulas and lancets. The methods involved cellular assays, biochemical assays, in silico models, and ex vivo models, and technologies involved are cell culture technologies, high-throughput technologies, and toxicogenomic, applied under various application involving neurotoxicity, dermal toxicity, cytotoxicity, and other applications. The various industry verticals included pharmaceuticals and biopharmaceuticals, cosmetic and household products, food, and chemicals.

What Is The In-Vitro Toxicology Testing Market Growth Forecast?

The in-vitro toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $20.87 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to advancements in toxicogenomics and predictive modeling, rising demand for personalized medicine safety testing, increasing investment in alternative testing technologies, expanding regulatory frameworks supporting in vitro methods, growth of biotechnology and biopharmaceutical pipelines. Major trends in the forecast period include increasing shift from in vivo to in vitro toxicology models, rising adoption of high-throughput screening technologies, growing demand for early-stage toxicity assessment in drug discovery, expansion of cell-based and organ-on-chip assays, increasing regulatory acceptance of alternative toxicology methods.

Global In-Vitro Toxicology Testing Market Segmentation

1) By Product And Service: Consumables, Assays, Equipment, Software, Services 2) By Technology: Cell Culture Technologies, High-throughput Technologies, Toxicogenomics 3) By Applications: Neurotoxicity, Dermal toxicity, Cytotoxicity, Other Applications 4) By Industry: Pharmaceuticals And Biopharmaceuticals, Cosmetic And Household Products, Food, Chemicals Subsegments: 1) By Consumables: Reagents, Cell Culture Media, Plates And Vials 2) By Assays: Cell-Based Assays, Biochemical Assays, Genetic Toxicity Assays 3) By Equipment: Automated Systems, Microscopes, Plate Readers 4) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Toxicology Modeling Software 5) By Services: Testing Services, Consultation Services, Regulatory Compliance Services

What Is The Driver Of The In-Vitro Toxicology Testing Market?

Growing healthcare expenditure is expected to propel the in-vitro toxicology testing market going forward. Health expenditure is the amount of money spent by citizens and the government out of total income on hospitals, home health services, prescription pharmaceuticals, nursing facilities, and personal healthcare. Health expenditure is increasing in the world due to the rising prevalence of disease which utilizes in-vitro toxicology testing. For instance, in September 2024, according to the report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, from 2023 to 2032, the average growth rate of national health expenditure (NHE) is projected to be 5.6%, surpassing the average GDP growth rate of 4.3%. As a result, the share of health spending as a percentage of GDP is expected to rise from 17.3% in 2022 to 19.7% in 2032. Therefore, the growing healthcare expenditure is driving the in-vitro toxicology testing industry.

Key Players In The Global In-Vitro Toxicology Testing Market

Major companies operating in the in-vitro toxicology testing market are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation

Global In-Vitro Toxicology Testing Market Trends and Insights

Major companies operating in the in-vitro toxicology testing market are adopting a strategic partnership approach to provide inhalation toxicology tests to strengthen their position. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in November 2024, Charles River Laboratories International Inc., a US-based provider of pharmaceutical products and services, collaborated with Met Tak life sciences, a US-based biotechnology company to develop a new approach methodology (NAM) inhalation toxicology test to reduce reliance on traditional animal research methods. By integrating MatTek's advanced 3D human tissue models into toxicology testing workflows, it can bridge the gap between animal testing and human biology.

What Are Latest Mergers And Acquisitions In The In-Vitro Toxicology Testing Market?

In September 2024, Scantox Group, a Denmark-based preclinical contract research organization specializing in toxicology, pharmacology, and regulatory safety studies, acquired Gentronix Ltd for an undisclosed amount. With this acquisition, Scantox Group gains access to Gentronix’s specialized in-vitro and genetic toxicology assay portfolio, GLP-compliant laboratory capabilities, and established client network, thereby expanding its regulatory toxicology capabilities while strengthening its operational scale and service breadth across early-stage safety assessment. Gentronix Ltd. is a UK-based biotechnology company that specializes in providing of genetic toxicology testing solutions, known for its expertise in in-vitro genotoxicity assays, skin toxicology studies, and predictive toxicology innovation.

Regional Outlook

North America was the largest region in the in- vitro toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the In-Vitro Toxicology Testing Market?

The in-vitro toxicology testing market includes revenues earned by entities by providing metabolic, toxicokinetic, and bioanalytical investigations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the In-Vitro Toxicology Testing Market Report 2026?

The in-vitro toxicology testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro toxicology testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.